Effects of vildagliptin, a DPP-4 inhibitor, in elderly diabetic patients with mild cognitive impairment-Reference-Cited by-同舟云学术

Effects of vildagliptin, a DPP-4 inhibitor, in elderly diabetic patients with mild cognitive impairment

Published:2019-09 Issue: Volume:84 Page:103896
ISSN:0167-4943
Container-title:Archives of Gerontology and Geriatrics
language:en
Short-container-title:Archives of Gerontology and Geriatrics

Author:

Borzì Antonio Maria^ORCID,Condorelli Giovanni^ORCID,Biondi Antonio^ORCID,Basile Francesco^ORCID,Vicari Enzo Saretto Dante^ORCID,Buscemi Carola^ORCID,Luca Salvatore^ORCID,Vacante Marco^ORCID

Publisher

Elsevier BV

Subject

Geriatrics and Gerontology,Gerontology,Aging,Health (social science)

Reference39 articles.

1. Antidiabetic drugs and their potential role in treating mild cognitive impairment and Alzheimer’s disease;Alagiakrishnan;Discovery Medicine,2013

2. Glucagon-like peptide-1 (GLP-1) diminishes neuronal degeneration and death caused by NGF deprivation by suppressing Bim induction;Biswas;Neurochemical Research,2008

3. Microbiological etiology of chronic skin lesions in type 2 diabetic subjects;Chisari;Infectious Disorders Drug Targets,2018

4. Effects of incretin-based therapies on neurocognitive function in humans: A systematic review of the literature;Dumbrill;Primary Care Diabetes,2018

5. GLP-1′s role in neuroprotection: a systematic review;Erbil;Brain Injury,2019

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Repurposing antidiabetic drugs for Alzheimer's disease: A review of preclinical and clinical evidence and overcoming challenges;Life Sciences;2024-10

2. GLP-1/GIP Agonist as an Intriguing and Ultimate Remedy for CombatingAlzheimer’s Disease through its Supporting DPP4 Inhibitors: A Review;Current Topics in Medicinal Chemistry;2024-07

3. The Contribution of Type 2 Diabetes to Parkinson’s Disease Aetiology;International Journal of Molecular Sciences;2024-04-15

4. Effects of DPP4 Inhibitors as Neuroprotective Drug on Cognitive Impairment in Patients with Type 2 Diabetes Mellitus: A Meta-Analysis and Systematic Review;International Journal of Endocrinology;2024-02-13

5. Neuroprotective effects of dipeptidyl peptidase 4 inhibitor on Alzheimer’s disease: a narrative review;Frontiers in Pharmacology;2024-02-09